Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients (vol 73, pg 439, 2010)

被引：0
|
作者：
Moscarelli, Luciano
机构：
来源：
CLINICAL NEPHROLOGY | 2016年 / 86卷 / 05期
关键词：
D O I：
10.5414/CNP86290
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [21] How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: According to blood pressure or proteinuria?
    Segura, J
    Christiansen, H
    Campo, C
    Ruilope, LM
    CURRENT HYPERTENSION REPORTS, 2003, 5 (05) : 426 - 429
  • [22] Ace in the Hole Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in the First Year after Heart Transplant
    Henricksen, E. J.
    Moayedi, Y.
    Lee, R.
    Han, J.
    Waddell, K.
    Luikart, H.
    Morales, D. P.
    Gordon, J.
    Lyapin, A.
    Duclos, S.
    Jimenez, S.
    Khush, K. K.
    Teuteberg, J. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S284 - S284
  • [23] Role of Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease
    Ram C.V.S.
    Vergne-Marini P.
    Current Hypertension Reports, 1999, 1 (5) : 431 - 435
  • [24] Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction
    Nakao, N
    Sakai, M
    Fujimori, A
    Fukagawa, M
    KIDNEY INTERNATIONAL, 2005, 68 (03) : 1375 - 1376
  • [25] Combination use of ACE inhibitors and angiotensin receptor blockers increases risk of life-threatening cardiac dysrhythmias
    Christian, Jennifer B.
    Eaton, Charles B.
    Hume, Anne L.
    Friedmann, Peter D.
    Jiang, Lan
    Lapane, Kate L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S233 - S233
  • [26] Angiotensin receptor blockers versus ACE inhibitors: Prevention of death and myocardial infarction in high-risk populations
    Epstein, BJ
    Gums, JG
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (03) : 470 - 480
  • [27] Prescription data related to the use of calcium channel blockers, ACE inhibitors and angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) in combination identify savings opportunities
    Carugo S.
    Rossetti G.
    Merlino L.
    Mancia G.
    High Blood Pressure & Cardiovascular Prevention, 2009, 16 (1) : 21 - 26
  • [28] Angiotensin Receptor Blockers and the Risk of Malignancy: A Note of Caution (vol 33, pg 709, 2010)
    Sica, D. A.
    DRUG SAFETY, 2010, 33 (11) : 1054 - 1054
  • [29] Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention
    Talbert, Robert L.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2010, 50 (05) : E116 - E125
  • [30] EXTENSIVE REVIEW OF PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF ACE-INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN CHILDREN WITH RENAL IMPAIRMENT
    Degraeuwe, Eva
    Sandra, Louis
    Devos, Paulien
    Gasthuys, Elke
    Snauwaert, Evelien
    Raes, Ann
    Vande Walle, Johan
    PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2876 - 2876
12345